C.C. Gould (Chemists) Limited - Accounts to registrar (filleted) - small 23.2.5

C.C. Gould (Chemists) Limited - Accounts to registrar (filleted) - small 23.2.5


IRIS Accounts Production v23.3.1.45 00604234 Board of Directors 1.6.22 31.5.23 31.5.23 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh006042342022-05-31006042342023-05-31006042342022-06-012023-05-31006042342021-05-31006042342021-06-012022-05-31006042342022-05-3100604234ns10:Originalns15:EnglandWales2022-06-012023-05-3100604234ns14:PoundSterlingns10:Original2022-06-012023-05-3100604234ns10:Originalns10:Director12022-06-012023-05-3100604234ns10:Original2022-06-012023-05-3100604234ns10:Original2023-05-3100604234ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012023-05-3100604234ns10:Originalns10:SmallEntities2022-06-012023-05-3100604234ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012023-05-3100604234ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3100604234ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3100604234ns10:Originalns10:FullAccounts2022-06-012023-05-3100604234ns10:Originalns10:Director22022-06-012023-05-3100604234ns10:Originalns10:RegisteredOffice2022-06-012023-05-3100604234ns10:Original2022-05-3100604234ns10:Originalns5:CurrentFinancialInstruments2023-05-3100604234ns10:Originalns5:CurrentFinancialInstruments2022-05-3100604234ns5:ShareCapitalns10:Original2023-05-3100604234ns5:ShareCapitalns10:Original2022-05-3100604234ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3100604234ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3100604234ns10:Original2021-06-012022-05-3100604234ns10:Originalns5:FurnitureFittings2022-05-3100604234ns10:Originalns5:FurnitureFittings2023-05-3100604234ns10:Originalns5:FurnitureFittings2022-05-3100604234ns10:Originalns5:CostValuation2022-05-3100604234ns10:Original2022-05-3100604234ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3100604234ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-012023-05-31
REGISTERED NUMBER: 00604234 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 May 2023

for

C.C. Gould (Chemists) Limited

C.C. Gould (Chemists) Limited (Registered number: 00604234)






Contents of the Financial Statements
for the Year Ended 31 May 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


C.C. Gould (Chemists) Limited

Company Information
for the Year Ended 31 May 2023







DIRECTORS: K Hampson
I Hampson





REGISTERED OFFICE: Annat
Tandridge Lane
Tandridge
Surrey
RH8 9NJ





REGISTERED NUMBER: 00604234 (England and Wales)





ACCOUNTANTS: Peter Hodgson & Co.
Chartered Accountants
Shadwell House
65 Lower Green Road
Tunbridge Wells
Kent
TN4 8TW

C.C. Gould (Chemists) Limited (Registered number: 00604234)

Statement of Financial Position
31 May 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - -
Investments 5 1,142 1,142
Investment property 6 242,000 242,000
243,142 243,142

CURRENT ASSETS
Cash at bank 10,065 9,272

CREDITORS
Amounts falling due within one year 7 21,800 21,659
NET CURRENT LIABILITIES (11,735 ) (12,387 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

231,407

230,755

CAPITAL AND RESERVES
Called up share capital 3,258 3,258
Retained earnings 8 228,149 227,497
SHAREHOLDERS' FUNDS 231,407 230,755

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 February 2024 and were signed on its behalf by:





I Hampson - Director


C.C. Gould (Chemists) Limited (Registered number: 00604234)

Notes to the Financial Statements
for the Year Ended 31 May 2023

1. STATUTORY INFORMATION

C.C. Gould (Chemists) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
There are no significant judgements or estimates pertaining to these accounts.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

In accordance with SSAP 19:
(i) Investment properties are revalued annually and the aggregate surplus or deficit is transferred to a revaluation reserve; and (ii) no depreciation or amortisation is provided in respect of leasehold investment properties with over 20 years to run.

The Companies Act 1985 requires tangible fixed assets to be depreciated systematically over their estimated useful economic lives. However, investment properties are held for investment rather than consumption; the directors therefore consider that depreciation on a systematic basis would not be appropriate in this case and that the accounting policy adopted is necessary for the accounts to give a true and fair view. Depreciation or amortisation is only one of the many factors reflected in the annual valuation and the amount which might otherwise have been shown cannot be separately identified or quantified.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


C.C. Gould (Chemists) Limited (Registered number: 00604234)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Functional currency
The company's functional currency is £ Sterling.

Financial instruments
Financial instruments including cash and bank balances are disclosed at fair value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 June 2022
and 31 May 2023 4,766
DEPRECIATION
At 1 June 2022
and 31 May 2023 4,766
NET BOOK VALUE
At 31 May 2023 -
At 31 May 2022 -

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 June 2022
and 31 May 2023 1,142
NET BOOK VALUE
At 31 May 2023 1,142
At 31 May 2022 1,142

C.C. Gould (Chemists) Limited (Registered number: 00604234)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 June 2022
and 31 May 2023 242,000
NET BOOK VALUE
At 31 May 2023 242,000
At 31 May 2022 242,000

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Tax 2,740 1,180
Directors' current accounts 18,260 19,760
Accrued expenses 800 719
21,800 21,659

8. RESERVES
Retained
earnings
£   

At 1 June 2022 227,497
Profit for the year 6,652
Dividends (6,000 )
At 31 May 2023 228,149

Included in reserves is the sum of £106,021 in connection with a fair market value adjustment of the company's investment properties.